Erratum to: Role of [18F]FDG PET in prediction of KRAS and EGFR mutation status in patients with advanced non-small-cell lung cancer

被引：0
|
作者：
Carlos Caicedo
Maria Jose Garcia-Velloso
Maria Dolores Lozano
Tania Labiano
Carmen Vigil-Diaz
Jose Maria Lopez-Picazo
Alfonso Gurpide
Javier J. Zulueta
Jose Angel Richter-Echevarria
Jose Luis Perez-Gracia
机构：
[1] University of Navarra,Nuclear Medicine Department, University Clinic of Navarra
[2] University of Navarra,Pathology Department, University Clinic of Navarra
[3] University of Navarra,Oncology Department, University Clinic of Navarra
[4] University of Navarra,Pulmonology Department, University Clinic of Navarra
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2014年 / 41卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2164 / 2164
相关论文
共 50 条
  • [1] Role of [18F]FDG PET in prediction of KRAS and EGFR mutation status in patients with advanced non-small-cell lung cancer
    Caicedo, Carlos
    Jose Garcia-Velloso, Maria
    Lozano, Maria Dolores
    Labiano, Tania
    Vigil Diaz, Carmen
    Maria Lopez-Picazo, Jose
    Gurpide, Alfonso
    Zulueta, Javier
    Richter Echevarria, Jose Angel
    Perez Gracia, Jose Luis
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 (11) : 2058 - 2065
  • [2] Role of [18F]FDG PET in prediction of KRAS and EGFR mutation status in patients with advanced non-small-cell lung cancer
    Carlos Caicedo
    Maria Jose Garcia-Velloso
    Maria Dolores Lozano
    Tania Labiano
    Carmen Vigil Diaz
    Jose Maria Lopez-Picazo
    Alfonso Gurpide
    Javier Zulueta
    Jose Angel Richter Echevarria
    Jose Luis Perez Gracia
    European Journal of Nuclear Medicine and Molecular Imaging, 2014, 41 : 2058 - 2065
  • [3] Role of [18F]-FDG-PET-CT in Prediction of Kras and EGFR Molecular Profile in Advanced Non-Small-Cell Lung Cancer Patients
    Caicedo, C.
    Garcia-Velloso, M.
    Lozano, M.
    Vigil Diaz, C.
    Lopez-Picazo, J.
    Gurpide, A.
    Zulueta, J.
    Richter Echevarria, J.
    Rodriguez-Fraile, M.
    Perez Gracia, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S223 - S224
  • [4] Prediction of EGFR and KRAS mutation in non-small cell lung cancer using quantitative 18F FDG-PET/CT metrics
    Minamimoto, Ryogo
    Jamali, Mehran
    Gevaert, Olivier
    Echegaray, Sebastian
    Khuong, Amanda
    Hoang, Chuong D.
    Shrager, Joseph B.
    Plevritis, Sylvia K.
    Rubin, Daniel L.
    Leung, Ann N.
    Napel, Sandy
    Quon, Andrew
    ONCOTARGET, 2017, 8 (32) : 52792 - 52801
  • [5] The correlation of mutation status of EGFR and KRAS with SUVmax of 18F-FDG-PET/CT in non-small-cell lungcancer
    Zhao, Bin
    Meng, Xiaxia
    Ma, Jingxin
    Xi, Rui
    Yuan, Ling
    Wu, Zhifang
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [6] 18F-FDG uptake for prediction EGFR mutation status in non-small cell lung cancer
    Guan, Jian
    Xiao, Nan J.
    Chen, Min
    Zhou, Wen L.
    Zhang, Yao W.
    Wang, Shuang
    Dai, Yong M.
    Li, Lu
    Zhang, Yue
    Li, Qin Y.
    Li, Xiang Z.
    Yang, Mi
    Wu, Hu B.
    Chen, Long H.
    Liu, Lai Y.
    MEDICINE, 2016, 95 (30)
  • [7] 18F-FDG uptake for prediction EGFR mutation status in non-small cell lung cancer
    Guan, Jian
    Chen, Longhua
    Xiao, Nanjie
    Chen, Min
    Zhang, Y.
    Li, Lu
    Yang, Mi
    Li, Qinyang
    Dai, Yongmei
    Zhang, Chi
    Liu, Laiyu
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [8] Predictive Value of Initial 18F-FDG PET/CT for Identifying EGFR and KRAS Mutations in Patients with Non-small-cell Lung Cancer
    Topuz, Ozge Vural
    Buyukpinarbasili, Nur
    HASEKI TIP BULTENI-MEDICAL BULLETIN OF HASEKI, 2024, 62 (05): : 255 - 264
  • [9] THE ROLE OF RADIOGENOMICS IN EGFR AND KRAS MUTATION STATUS PREDICTION AMONG NON-SMALL CELL LUNG CANCER PATIENTS
    Freitas, C.
    Pereira, T.
    Pinheiro, G.
    Dias, C.
    Hespanhol, V.
    Costa, J. L.
    Cunha, A.
    Oliveira, H.
    CHEST, 2020, 157 (06) : 16A - 16A
  • [10] Comparison of Hypermetabolic and Hypoxic Volumes Delineated on [18F]FDG and [18F]Fluoromisonidazole PET/CT in Non-small-cell Lung Cancer Patients
    Sébastien Thureau
    R. Modzelewski
    P. Bohn
    S. Hapdey
    P. Gouel
    B. Dubray
    P. Vera
    Molecular Imaging and Biology, 2020, 22 : 764 - 771
12345